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Identification of a Recognizable Progressive
Skeletal Dysplasia Caused by RSPRY1 Mutations
Maha Faden,1,12 Fatema AlZahrani,2,12 Roberto Mendoza-Londono,3,4,12 Lucie Dupuis,3,4 Taila Hartley,5
Peter Kannu,3,4 Julian A. Raiman,3 Andrew Howard,4,6 Wen Qin,5 Martine Tetreault,7,8
Joan Qiongchao Xi,9 Imadeddin Al-Thamer,10 Care4Rare Canada Consortium, Richard L. Maas,9
Kym Boycott,5 and Fowzan S. Alkuraya2,11,*
Skeletal dysplasias are highly variable Mendelian phenotypes. Molecular diagnosis of skeletal dysplasias is complicated by their extreme
clinical and genetic heterogeneity. We describe a clinically recognizable autosomal-recessive disorder in four affected siblings from a
consanguineous Saudi family, comprising progressive spondyloepimetaphyseal dysplasia, short stature, facial dysmorphism, short
fourth metatarsals, and intellectual disability. Combined autozygome/exome analysis identified a homozygous frameshift mutation
in RSPRY1 with resulting nonsense-mediated decay. Using a gene-centric ‘‘matchmaking’’ system, we were able to identify a Peruvian
simplex case subject whose phenotype is strikingly similar to the original Saudi family and whose exome sequencing had revealed a
likely pathogenic homozygous missense variant in the same gene. RSPRY1 encodes a hypothetical RING and SPRY domain-containing
protein of unknown physiological function. However, we detect strong RSPRY1 protein localization in murine embryonic osteoblasts
and periosteal cells during primary endochondral ossification, consistent with a role in bone development. This study highlights the
role of gene-centric matchmaking tools to establish causal links to genes, especially for rare or previously undescribed clinical entities.Skeletal dysplasias are a relatively common group of disor-
ders involving the skeletal system with an estimated birth
prevalence of 3 per 10,000.1 The resulting physical and
radiographic phenotype is highly variable and ranges
from embryonic lethality to very mild phenotypes that
might not come to medical attention. Major efforts to
compartmentalize these disorders into clinically and radio-
logically recognizable entities to facilitate the study of their
pathogenesis and natural history have led to the Nosology
and Classification of Genetic Skeletal Disorders, which
currently include 456 distinct disease headings.2
The extreme phenotypic heterogeneity of skeletal dys-
plasias pose a practical challenge in arriving at the correct
diagnosis, which until recently was a pre-requisite for the
establishment of the underlying genetic cause. Recently,
genomic tools have proven very effective in uncovering
causal mutations even in cases where no specific clinical
diagnosis could be established, thereby ushering in the
era of ‘‘genotype first’’ approach.3,4 This approach has
proven extremely valuable in such heterogeneous disor-
ders as neurogenetic diseases.5,6 Recently, we have shown
in a large study that previously established OMIM
genes account for fewer than 50% of skeletal dysplasia
cases, which suggests that many more novel disease-
gene links have yet to be established.7 In this study, we
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608 The American Journal of Human Genetics 97, 608–615, Octoberdysplasia and show that this condition is probably caused
by biallelic mutations in RSPRY1 through a combination of
exome sequencing, autozygome analysis, and gene-centric
matchmaking.
The index individual (family 1_IV:3) is a 13-year-old
Saudi girl who presented with short stature and progressive
inability to walk. Her Bedouin family lives a nomadic life in
the desert and had largely avoided contact with the medi-
cal system. She was a product of full-term NSVD after an
uneventful pregnancy. She has history of delayed motor
milestones, walking at 5 years of age but now wheelchair
bound after she progressively lost the ability to walk. Her
cognitive development was significantly delayed but she
never had a formal IQ assessment. She can follow simple
commands and her expressive language is severely limited.
The family history is significant for first-degree consan-
guinity between the healthy parents and the presence of
three similarly affected siblings who had not been brought
to medical attention (Figure 1). Physical examination re-
vealed poor weight gain (18 kg, 4.2 SD), severe short stat-
ure (100 cm, 8.2 SD), microcephaly (48 cm, 4.4 SD)
with flattened occiput, and facial dysmorphism (hyperte-
lorism, epicanthal folds, mild ptosis, strabismus, malar hy-
poplasia, short nose, depressed nasal bridge, full lips, small
low-set ears, and short neck). Musculoskeletal examination
was remarkable for short hands, malformed feet (rockerArabia; 2Department of Genetics, King Faisal and Research Center, Riyadh
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Figure 1. Identification of a Distinct Skeletal Dysplasia Syndrome
(A and B) Pedigrees of families 1 and 2.
(C and D) Facial images of family 1_IV:3 showing hypertolerism, epicanthal folds, partial ptosis, squint, malar hypoplasia, short nose,
depressed nasal bridge, full lips, and short neck.
(E) Facial image of family 1_IV:6 showing frontal bossing, hypertolerism, partial ptosis but no squint, prominent cheeks with visible
small vessels, short nose, mild depressed nasal bridge, full lips, low-set ears, and short neck.
(F) Hands of family 1_IV:3 are short and broad with short fingers and dysplastic nails.
(G) Hand radiographs of family 1_IV:6 showing small epiphysis of the both radius and ulna, mild irregularities of the metaphyses, and
small-for-age carpal bones (micro carpal bones).
(H) Feet of family 1_IV:3 showing proximal insertion of the fourth toe that overlaps the third toe, lateral deviation of the big toe,
dysplastic toenails, and partial syndactyly of the second and third toes.
(legend continued on next page)
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Table 1. Summary of the Clinical and Radiographic Features of
the Two Study Families
Family 1 Family 2
IV:1 IV:2 IV:3 IV:6 II:1
Gender F F F M M
Age at assessment (years) 18 16 13 9.5 7.5
Short stature þ þ þ þ þ
ID þ þ þ þ 5
Delayed motor development þ þ þ þ þ
Delayed bone age þ þ þ þ þ
Microcephaly þ þ þ þ þ
Facial dysmorphism þ þ þ þ þ
Overriding toes þ þ þ þ þ
Scoliosis þ þ þ þ þ
Craniosynostosis þ þ þ þ 
Small carpal bones þ þ þ þ þ
Platyspondyly þ þ þ þ þ
Coxa deformity þ þ þ þ þ
Genu deformity þ þ þ þ þ
Short femoral neck þ þ þ þ þ
Short fourth metatarsal þ þ þ þ þ
Cupped and frayed
metaphysis
þ þ þ þ þbottom heel with overriding toes), knocked knees, and
mild scoliosis. There was generalized hypotonia with pre-
served deep tendon reflexes and reduced muscle power.
Skeletal survey revealed generalized osteopenia, copper-
beaten appearance of the skull with premature closure of
sutures, short metacarpal bones, delayed bone age, platy-
spondyly, anterior wedging and posterior scalloping of
the lower thoracic vertebras, and mild-moderate thoraco-
lumber scoliosis. In addition, there was evidence of narrow
pelvis, bilateral coxa vara, increased right acetabular angle,
short and slender long bones, small epiphysis, cupping
and fraying of the metaphyses of the tibia and fibula, slip-
ped capital femoral epiphyses, short femoral neck, and
mild distal femoral bowing. Subluxation of the left patella
and a small non-ossified fibroma in the left femur were also
noted. Importantly, the overriding toes were found to be
secondary to marked shortening of the fourth metatarsal
bilaterally. Parents subsequently brought the three report-(I) Foot radiographs of family 1_IV:1 showing severely short third an
(J–L) Radiographs of family 1_IV:1 (J), 2 (K), and 3 (L) showing a rem
epiphysis (genu valgum deformity is easily seen in L).
(M and N) Clinical photographs of family 2_II:1 at 5 (M) and 7.5 (N)
hypertelorism, short nose, tented upper lip, and low-set ears, as well
(O) Hand radiograph showing small carpal bones.
(P) Pelvis radiograph showing immature flat femoral epiphysis.
(Q) Spine radiograph showing exaggerated lordosis with platyspond
(R) Marked genu deformity of both knees.
610 The American Journal of Human Genetics 97, 608–615, Octoberedly affected siblings for medical evaluation and all had
strikingly similar clinical and radiographic findings as sum-
marized in Table 1 and Figure 1. Interestingly, the severity
of the skeletal dysplasia appeared to correlate with the age
e.g., the findings in the 18-year-old sister were more severe
than those in the 9-year-old brother. We were able to
perform a limited set of additional tests such as CT brain
in the index individual, which revealed asymmetry of cere-
bral hemispheres, lateral ventricles, orbits, and skull, and
there was evidence of premature closure of right coronal
suture on 3D rendering of the CT skull. Ultrasound of
abdomen and pelvis was normal as was cardiac echocardio-
gram and fundus examination.
The above findings suggested a highly distinct form of
spondyloepimetaphyseal dysplasia (SEMD), most likely
autosomal recessive in inheritance. Therefore, we recruited
the family under an IRB-approved research protocol
(KFSRHC RAC# 2080006), obtained written informed con-
sent, and drew blood in EDTA and PAXGene tubes for DNA
and RNA extraction, respectively. Autozygome analysis
was performed as described before.8,9 In brief, DNA from
all family members was run on Axiom SNP Chip (Affyme-
trix) for genome-wide genotyping according to the manu-
facturer’s protocol. The resulting genotyping files were
interrogated for runs of homozygosity that are >1 Mb
in size as surrogates of autozygosity using AutoSNPa.10
Only two autozygous blocks were found to be exclusively
shared by the affected members of the family. The first
is chr16: 17,909,383–31,695,263 and the other is
chr16: 52,478,215–58,313,806 (Figure 2). Both loci were
further verified by linkage analysis performed with
easyLINKAGE11 (Figure 2). None of the 405 genes within
these two intervals is known to cause a similar phenotype
when mutated. Therefore, we proceeded with whole
exome sequencing using DNA from the index individual.
Exome capture was performed with TruSeq Exome Enrich-
ment kit (Illumina) according to the manufacturer’s proto-
col. Samples were prepared as an Illumina sequencing
library, and in the second step, the sequencing libraries
were enriched for the desired target with the Illumina
Exome Enrichment protocol. The captured libraries were
sequenced with Illumina HiSeq 2000 Sequencer. The reads
are mapped against the UCSC Genome Browser. The SNPs
and indels were detected by SAMTOOLS. We considered
only very rare (MAF < 0.001) coding/splicing homozygous
variants within the two critical autozygous intervals
(Figure 2). The only variant that fit this definition was a
homozygous 1 bp duplication in RSPRY1 that predictsd fourth metacarpals.
arkably similar pattern of bilateral coxa vara and small flat femoral
years showing facial dysmorphism in the form of epicanthal folds,
as short neck and marked genu deformity.
ylyl.
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Figure 2. Identification of Mutations in
RSPRY1 in Families with a Distinct Skeletal
Dysplasia Syndrome
(A) Output of AutoSNPa on family 1
showing the two critical autozygous inter-
vals on chr16 that are exclusively shared
by the affected members (RSPRY1 locus
indicated by blue triangle). Each column
represents one sample (affected on the
left and unaffected on the right) and
each row represents the call of one SNP
where black is homozygous and yellow is
heterozygous.
(B) Genome-wide linkage analysis shows
two adjacent peaks corresponding to the
two ROHs shown in (A).
(C) Filtering strategy of the exomic variants
generated on family 1_IV:1 showing a sin-
gle surviving variant in RSPRY1.
(D) Cartoon of RSPRY1 with the sequence
chromatograms of the two mutations.
The strong cross-species conservation of
the mutated Gly41 residue in family 2 is
also shown.
(E) Upper panel is the result of an RT-PCR
experiment showing marked reduction of
RSPRY1 transcript as a result of NMD
in the blood of affected members of fam-
ily 1. Lower panel is the summary of two
independent real-time RT-PCR experi-
ments (each with technical triplicates)
confirming the reduction of RSPRY1 tran-
script in all affected members of family 1.frameshift and premature truncation (GenBank: NM_
133368.1; c.1279dupA [p.Thr427Asnfs*10]). Segregation
of this variant with the disease was confirmed by Sanger
sequencing in all family members. This variant is absent
in 615 Saudi exomes, as well as the ExAC Consortium.
Furthermore, RT-PCR revealed significant reduction (72%
[46%–86%], p < 0.0001) of the RSPRY1 transcript in blood
of affected individuals compared to control subjects, most
likely due to NMD (Figure 2).
As part of the collaboration between KFSHRC and
Care4Rare Canada (both members of International Rare
Disease ResearchConsortium [IRDiRC]), wehad each estab-
lished a matchmaking tool in which our respective data-
bases could be screened for variants in likely disease-linked
genes. The resulting matrix can then be queried whenever
KFSHRCorCare4Rare Canada investigators identify a likely
disease-causing variant in a gene not previously linked to
disease. After failing to identify any match in KFSHRC
matchmaking system, we queried the matchmaker at
Care4Rare Canada and identified a single unsolved affectedThe American Journal of Human Gindividual in whom exome se-
quencing had identified a homozy-
gous deleterious-appearing variant in
RSPRY1. Review of the clinical history,
presentation, and radiological find-
ings support the notion that these
two affected individuals have similar
phenotypes as detailed below.The Care4Rare Canada index individual (family 2_II:1)
was an 8-year-oldmale of Peruvian ancestry who presented
to the genetics clinic for evaluation because of significant
speech delay. He was the first and only pregnancy of a
36-year-old mother. This individual was delivered at
36 weeks gestation because of premature rupture of mem-
branes. His birth weight was 2.85 kg. The parents deny
known consanguinity but come from an isolated and small
region in Peru and there is family history of a similar con-
dition. Developmental delay was evidenced by his delayed
walking until 23months of age and inability to use a spoon
and limited speech when he first presented at 3 years of
age. He was formally assessed and diagnosed with autism
spectrum disorder at 5 years of age. At 7.5 years of age,
his expressive language was limited to 20 words that
only people close to him recognize, but he was able to write
his name.
When first examined at 3 years of age, his height was
91 cm (10th centile), weight 14 kg (40th centile), and
head circumference 53.5 cm (þ2.5 SD). His height showedenetics 97, 608–615, October 1, 2015 611
gradual deceleration with age; it was 91.5 cm at 4 years
(2.6 SD), 95.6 cm at 5 years (2.8 SD), and 112.4 cm at
7.5 years (4 SD). Throughout his follow-up visits, he
had no corneal or lens clouding, no organomegaly,
and normal male genitalia. Facial dysmorphic features
included epicanthal folds, hypertelorism, short nose,
tented upper lip, and low-set ears (Figure 1). Musculoskel-
etal examination revealed gradually increasing limited
extension of the elbow, distal hyperextensibility, over-
riding toes, and short trunk with hyperlordosis. His skin
was normal. At 8 years of age he developed significant
valgus deformity of the left knee and varus deformity of
the right knee necessitating surgical correction. The neuro-
logical examination revealed normal tone and power.
Skeletal survey at 3 years of age showed marked epiphy-
seal maturation defect. There was also some frontal boss-
ing, steep floor of the cranial fossa, and mild cervical and
thoracic platyspondyly. Skeletal survey at 5 years of age
showed significant delay in epiphyseal maturation. The
proximal ends of the metacarpals showed mild pointing
of the proximal ends. In the pelvis there was flattened
and irregular femoral heads with adequate coverage by
the acetabulum. Mild scoliosis of the thoracolumbar spine
was noted. Delayed epiphyseal maturation was also noted
at 8 years of age along with flattening of femoral heads,
thoracic platyspondyly, and short fourth metatarsals
(Figure 2).
Urine was negative for glycosaminoglycans and oligo-
saccharides. Liver function tests, thyroid function tests,
and basic blood biochemistry were consistently normal.
Microarray analysis (aCGH) on an oligo array 44K platform
was normal. Echocardiogram and abdominal ultrasound
were normal. MRI of the brain at 5 years of age showed
asymmetric prominent lateral ventricles with squaring
off of the frontal horns and mild thinning of the anterior
body of the corpus callosum. Light and electron micro-
scopy of skin fibroblasts was normal.
Whole-exome sequencing was performed on genomic
DNA after obtaining approval from the Institutional Re-
view Board of the Hospital for Sick Children and informed
consent from the family. DNA was captured with the
SureSelect Human All Exon Kit v5 (Agilent Technologies)
and sequenced on an Illumina HiSeq 2000 platform with
paired-end 100 bp reads (McGill University and Genome
Quebec Innovation Center). Read alignment to human
genome hg19, variant calling, and annotation were done
with a pipeline based on BWA (v.0.5.9), SAMtools
(v.0.1.17), ANNOVAR, and custom annotation scripts as
described previously.12,13 Variants with possible protein
altering effects (nonsense, frameshift, indel, splicing, and
missense) with an allele frequency >1% in either the
1000 Genomes database or the NHLBI/NHGRI Exome
Project (v.0.0.14, June 20, 2012), seen in >30 individuals
in our exome database (more than 2,000 exomes), or that
occurred as homozygotes in the ExAC database were
excluded (Table S1). The final list of variants is listed in
Table S2.612 The American Journal of Human Genetics 97, 608–615, OctoberBased on the similarity in phenotype with the Saudi
family, we were particularly interested in one rare
homozygous missense variant (GenBank: NM_133368.1;
c.121G>T [p.Gly41Cys]) in a conserved residue (GERP
5.22, Phast 658) in RSPRY1 (Figure 2). This variant was
not present in dbSNP, 1000 Genomes, the NHLBI/NHGRI
Exome Project, or the ExAC database and was not previ-
ously seen in our in-house exome database. Moreover,
the variant was predicted to be damaging by four dif-
ferent bioinformatics algorithms (SIFT [0.04], PolyPhen-2
[0.98], MutationTaster [0.99], and CADD [24.7]). Sanger
sequencing confirmed that the variant was homozygous
in the affected individual and that both parents were
heterozygous.
As shown in Table 1, the affected individuals from both
families have a strikingly similar clinical profile comprising
overlapping facial dysmorphism, progressive SEMD, scoli-
osis, intellectual disability, brain asymmetry, and short
fourth metatarsals. Craniosynostosis was observed in all
four Saudi siblings but not in the Peruvian individual, so
this might be another clinical feature of the disorder and
its absence in the Peruvian individual might reflect the
potentially milder effect of his missense mutation as
compared to the null Saudi mutation. Nonetheless, there
is sufficient clinical resemblance between the two families
to conclude that they represent a single clinical entity,
which we propose to be a distinct subtype of SEMD caused
by loss of function of RSPRY1.
RSPRY1 is a protein with a RING and SPRY domains that
is subjected to ubiquitination.14–17 Although virtually
nothing is known about the function of RSPRY1, we can
make speculations based on other proteins known to
contain the SPRY domain and might be relevant to the
phenotype. For example, Sprouty1, 2, and 4 are all SPRY-
containing proteins and inhibit FGF signaling. Spry4 KO
mice display dwarfism and abnormal digit development
whereas Spry2/Spry4 double KO mice have severe defects
in craniofacial and limb development, probably mediated
by enhanced FGF signaling.18 Future work will clarify
whether cells derived from individuals with RSPRY1 muta-
tions have enhanced FGF signaling, whichmight provide a
mechanistic link to the associated phenotype.
To gain further evidence of causality for RSPRY1 loss of
function in the SEMD disorder observed in the Saudi and
Canadian kindreds and insight into function, we exam-
ined the expression of Rspry1 transcripts and the localiza-
tion of the encoded protein by in situ hybridization,
RT-PCR, and immunohistochemistry (IHC) in mid- to
late-gestation mouse embryos and newborns. For IHC,
we employed an affinity-purified rabbit polyclonal Novus
antibody NBP1-92358, directed against residues 87–233
of full-length human RSPRY1, which contains only one
amino acid difference frommouse in this region. The spec-
ificity of the RSPRY1 antibody via peroxidase or AP-
coupled secondary antibody detection on paraffin and
frozen sections was established by comparing Rspry1 sec-
tion in section in situ hybridization results by using a1, 2015
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Figure 3. RSPRY1 Is Localized in Mouse
Embryonic Bone and Surrounding Muscle
Tissues during Primary Endochondral Ossi-
fication
(A–C) RSPRY1 protein localization in E18.5
mouse upper limb at the stylopod-zeugo-
pod junction of the humerus and ulna
(elbow). There is strong localization in the
perichondrium and periosteum surround-
ing both bones and in presumptive osteo-
blasts andosteocytes (arrows) in developing
cancellous bone in the humerus. Higher
magnification shown in (B) (boxed region
in A; with control staining of an IgG-treated
section, inset) and (C), which represents a
frozen section. Note the relative paucity of
expression in hyaline cartilage in the ulna
in (A) and strong expression in forelimb
skeletal muscle surrounding both bones.
Scale bars represent 300 mm in (A) and
40 mm in (B) and (C).
(D) RSPRY1 is strongly localized in distal
femur perichondrial tissue at E18.5 (arrow).
Note also staining in the fibromuscular
connections to the fibula and tibia at the
knee joint. Scale bar represents 300 mm.
(E and F) RSPRY1 localization in perichon-
drial tissues in tarsals (E) and metatarsals
(F) (arrows) at E18.5, again coinciding
with tissues affected in the described syn-
drome. Scale bars represent 300 mm.
(G and H) Tibial and tarsal localization of
RSPRY1 at E18.5 in periosteum and per-
chondrium, the latter shown at higher
magnification in (H). Note localization is
stronger in a more internal perichondrial
layer (arrow). Scale bars represent 200 mm
in (G) and 40 mm in (H).526 bp riboprobe to mouse Rspry1 exon 15 30 UTR with the
IHC results in E12.5 mouse embryos.
Rspry1 transcripts and encoded protein were expressed
in and localized to, respectively, intact mouse limb bud
mesenchyme from as early as E12.5. At E18.5, coinciding
with primary ossification in the mouse, RSPRY1 protein
was abundantly detected in most developing endochon-
dral bones and in skeletal muscles, as well as in developing
heart, kidney, and brain (Figures 3A–3H and S1). In the
E18.5 forelimb, RSPRY1 was detected in the humerus,
ulna, radius, carpals, and metacarpals (Figures 3A–3C and
S2). RSPRY1 was detected in similar fashion in the bones
of the E18.5 hindlimb, including the femur, tibia, fibula,
tarsals, and metatarsals (Figures 3D–3H). Strong localiza-
tion was detected in both osteoblasts and osteocytes
within these bones, with minimal localization in chondro-
cytes (Figures 3B and 3C). A second site of prominent
RSPRY1 bone localization was in the perichondrium and
periosteum, with the highest levels in the innermost,
cellular layer (Figure 3H). In sum, the expression of Rspry1
correlates strikingly with the skeletal defects observed in
affected individuals and is also consistent with the pres-
ence of brain and craniofacial phenotypes, because expres-
sion was detected in embryonic and postnatal brain and in
developing craniofacial tissues (Figure S1 and data notThe Americshown). Although the embryonic expression of Rspry1 ac-
counts for the presence of congenital skeletal dysplasia,
further studies will be required to determine whether the
progressive nature of the skeletal dysplasia in these families
reflects a postnatal requirement for Rspry1 osteogenic
expression. In addition, the strong Rspry1 expression in
developing skeletal muscle raises the possibility that mus-
cle defects might also contribute to the ambulatory defects
in affected individuals.
Given the rate at which genes linked to Mendelian dis-
eases have been identified since the introduction of
genomic sequencing tools, it is inevitable that increasingly
rare disorders will be the next frontier in gene discovery in
the context of human diseases. For such rare disorders,
especially novel ones, it is particularly challenging to
achieve the gold standard of identifying more than one
family with likely pathogenic mutations in the same
gene and significant phenotype overlap to establish a
causal disease-gene link. However, the increasing use of
whole-exome and whole-genome sequencing in individ-
uals with rare or novel phenotypes presents an opportu-
nity for innovative matchmaking solutions. Some efforts
have focused on phenotypic matchmaking via HPO
terms;19 however, the very well-established phenomenon
of phenotypic variability in clinical genetics has thean Journal of Human Genetics 97, 608–615, October 1, 2015 613
potential to limit the usefulness of purely phenotype-
driven tools. On the other hand, a gene-centric approach
that allows matchmaking based on candidate genes can
link the investigators who can then vet the phenotypic
data in detail to make a conclusion regarding the degree
of overlap. Indeed, the matching of the two families we
present here is a good example of the power of the ‘‘geno-
type-first’’ matchmaking approach. Because the two
groups of investigators (in Saudi Arabia and Canada)
were linked through amatchmaking tool that took into ac-
count only the fact that we each had a candidate causal
variant in RSPRY1, it was possible to conduct a thorough
and joint analysis of the phenotype and conclude that it
is very likely the same. A similar and large-scale approach
based on genotype-driven matches is the web-based tool
GeneMatcher, which links investigators with interest in
the same gene.20 Ideally, as we move forward, the develop-
ment of more sophisticated matchmaking tools based on
automated analysis of both phenotype and genotype will
contribute significantly to the identification of the genes
for these ultra-rare conditions. One such example of this
type of approach is PhenomeCentral, and optimization
and connection of these types of databases to each other
will accelerate the pace of discovery.
In conclusion, we report a distinct subtype of SEMD
characterized by severe short stature, facial dysmorphism,
short fourth metatarsals, and intellectual disability with
or without craniosynostosis. Our findings demonstrate
that loss-of-function mutations in RSPRY1 are the likely
cause of this skeletal dysplasia, although the mechanism
remains unclear. Our study highlights the usefulness of
gene-centric matchmaking tools in accelerating the discov-
ery of genes, especially for exceedingly rare or novel Men-
delian disorders.Supplemental Data
Supplemental Data include two figures and two tables and can be
found with this article online at http://dx.doi.org/10.1016/j.ajhg.
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